Variant report
Variant | esv3473865 |
---|---|
Chromosome Location | chr6:24325348-24327812 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146524316 | chr6:24325364-24325365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531390753 | chr6:24325371-24325372 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530012741 | chr6:24325376-24325377 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566757551 | chr6:24325443-24325444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs578074442 | chr6:24325460-24325461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538621387 | chr6:24325478-24325479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140975609 | chr6:24325499-24325500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368465660 | chr6:24325553-24325554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568965581 | chr6:24325619-24325620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1417740 | chr6:24325627-24325628 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs372418519 | chr6:24325633-24325634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368228478 | chr6:24325638-24325639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74826230 | chr6:24325662-24325663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534487233 | chr6:24325663-24325664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554204120 | chr6:24325665-24325666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs13191367 | chr6:24325680-24325681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181312430 | chr6:24325685-24325686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144788122 | chr6:24325699-24325700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537914609 | chr6:24325700-24325701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148208189 | chr6:24325728-24325729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568347955 | chr6:24325768-24325769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575398372 | chr6:24325787-24325788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556241500 | chr6:24325802-24325803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140245048 | chr6:24325804-24325805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12211069 | chr6:24325883-24325884 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs538623168 | chr6:24325906-24325907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs546787433 | chr6:24325956-24325957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183953595 | chr6:24325997-24325998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150294904 | chr6:24326025-24326026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552248822 | chr6:24326036-24326037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568951544 | chr6:24326038-24326039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs537949018 | chr6:24326067-24326068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548307437 | chr6:24326104-24326105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189117853 | chr6:24326136-24326137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369308706 | chr6:24326208-24326209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544003171 | chr6:24326246-24326247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554344200 | chr6:24326290-24326291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571015225 | chr6:24326297-24326298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540163455 | chr6:24326320-24326321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200283757 | chr6:24326363-24326364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71760858 | chr6:24326383-24326384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs386698081 | chr6:24326385-24326386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374659562 | chr6:24326394-24326395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558581575 | chr6:24326398-24326399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575339800 | chr6:24326399-24326400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112811405 | chr6:24326414-24326415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149425020 | chr6:24326418-24326419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201247740 | chr6:24326421-24326422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377136913 | chr6:24326422-24326423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370597196 | chr6:24326426-24326427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Uveal melanoma | 20484589 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:24316400-24326800 | Weak transcription | Pancreas | Pancrea |
2 | chr6:24322400-24325400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr6:24323600-24325600 | Enhancers | A549 | lung |
4 | chr6:24323800-24325400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:24324000-24325400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr6:24324200-24329400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr6:24324400-24332000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr6:24324600-24325400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr6:24324600-24329200 | Weak transcription | NHEK | skin |
10 | chr6:24324600-24330000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
11 | chr6:24324600-24332000 | Weak transcription | HMEC | breast |
12 | chr6:24324600-24332200 | Weak transcription | HSMMtube | muscle |
13 | chr6:24324800-24329000 | Weak transcription | Fetal Kidney | kidney |
14 | chr6:24325000-24325400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
15 | chr6:24325000-24329000 | Weak transcription | NH-A | brain |
16 | chr6:24325000-24329400 | Enhancers | HepG2 | liver |
17 | chr6:24325600-24328200 | Weak transcription | A549 | lung |
18 | chr6:24326800-24327400 | Enhancers | Pancreas | Pancrea |
19 | chr6:24327400-24327800 | Enhancers | Fetal Brain Female | brain |
20 | chr6:24327400-24339200 | Weak transcription | Pancreas | Pancrea |
21 | chr6:24327800-24328200 | Weak transcription | Fetal Brain Female | brain |